BioSpace News Archive

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Peter Wilver has been elected to the Board of Directors, effective immediately.

Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida.

PatientBond, the leading consumer science-driven patient engagement SaaS provider, announced today a collaboration with Zyter, Inc., the ultimate digital healthcare platform for pre-emptive and post-acute conditions, enabled by an ecosystem of Zyter products, which support value-based care initiatives.

Nyquist Data, Inc., the leading intelligence platform for medical technology, announces today that it has entered into a commercial partnership with Clarivate Plc, a global leader in providing trusted information and insights to accelerate the pace of innovation.

Increasing prevalence of chronic diseases across the globe, rising need for automated solutions to manage large patient database, and increasing number of EHR service providers are some key factors expected to drive global Electronic Health Records market growth.

Rising prevalence of cerebral palsy across the globe, increasing healthcare spending, and rising investments in R&D activities are some key factors expected to drive global Cerebral Palsy market growth.

Increasing prevalence of chronic diseases, rising geriatric population, and rapid advancements in electroceutical devices are some key factors expected to drive global Bioelectric Medicine market growth.

A simple diagnostic procedure, followed by an interventional radiology treatment known as fallopian tube recanalization, could allow a high percentage of women struggling with infertility from blocked fallopian tubes to conceive with less involved or, in some cases, no further invasive fertility procedures, according to new research presented at the Society of Interventional Radiology Annual Scientific Meeting.

Aesthetic medicine is an emerging field t that focuses on altering cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration, and spider veins among others.

The Biosimilars Market size is expected to reach USD 88.12 Billion in 2030 and register a revenue CAGR of 21.3% over the forecast period, according to the latest report by Reports and Data.